H.R. 1’s limits on Medicaid eligibility for certain immigrants -- a provision the National Association of Medicaid Directors head worried hasn't been publicly discussed enough and that beneficiary ...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

Log in to access this content.

A new AARP report analyzes the tactics AstraZeneca used to prevent lower-cost alternatives to its blockbuster inhaler Symbicort from entering the market when the brand drug’s exclusivity period was ...

The Advanced Research Projects Agency for Health (ARPA-H) announced prize winners last month that collectively will receive $87 million for a new program intended to develop methods to produce, store ...

As several pharmacy benefit manager reform bills move through Congress, the top PBM lobby is leveraging a new government report to refute criticism that PBM-owned pharmacies under Medicare Part D ...

FDA’s push to find new members for its advisory committees could reshape the agency’s key panel that provides recommendations on vaccine approvals, adding up to 10 new members.

The latest KFF Health Tracking Poll finds consumers have deep concerns about affordability with a quarter of respondents saying they are “very worried” about the costs of healthcare and gas prices, ...

Congress should reauthorize the Older Americans Act's (OAA) reporting requirements, program integrity safeguards and accountability measures, HHS Secretary Robert F. Kennedy Jr. said in a recent ...

A new benchmark system designed to measure and track the structural fragility of the nation’s drug supply chain shows more than 550 million prescriptions were filled in 2023 for medicines with high or ...

Florida Attorney General James Uthmeier is suing Pfizer and its CEO Albert Bourla, chair of the Pharmaceutical Research and Manufacturers of America, over the marketing of Pfizer’s COVID-19 vaccine, ...